183 related articles for article (PubMed ID: 33783412)
1. Barriers to and Facilitators of Human Papillomavirus Vaccination Among People Aged 9 to 26 Years: A Systematic Review.
Zheng L; Wu J; Zheng M
Sex Transm Dis; 2021 Dec; 48(12):e255-e262. PubMed ID: 33783412
[TBL] [Abstract][Full Text] [Related]
2. Facilitators and barriers of human papillomavirus vaccine uptake in young females 18-26 years old in Singapore: A qualitative study.
Lim ASE; Lim RBT
Vaccine; 2019 Sep; 37(41):6030-6038. PubMed ID: 31473002
[TBL] [Abstract][Full Text] [Related]
3. Acceptability of and barriers to human papillomavirus vaccination in China: A systematic review of the Chinese and English scientific literature.
Wang D; Wu J; Du J; Ong H; Tang B; Dozier M; Weller D; Campbell C
Eur J Cancer Care (Engl); 2022 May; 31(3):e13566. PubMed ID: 35229931
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus (HPV) vaccination in the transition between adolescence and adulthood.
Glenn BA; Nonzee NJ; Tieu L; Pedone B; Cowgill BO; Bastani R
Vaccine; 2021 Jun; 39(25):3435-3444. PubMed ID: 33992435
[TBL] [Abstract][Full Text] [Related]
5. Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature.
Holman DM; Benard V; Roland KB; Watson M; Liddon N; Stokley S
JAMA Pediatr; 2014 Jan; 168(1):76-82. PubMed ID: 24276343
[TBL] [Abstract][Full Text] [Related]
6. Knowledge, attitudes, and practices related to human papillomavirus vaccination among college students in a state university: Implications for nurse practitioners.
D'Errico MP; Tung WC; Lu M; D'Errico R
J Am Assoc Nurse Pract; 2020 Jun; 33(9):709-718. PubMed ID: 32590447
[TBL] [Abstract][Full Text] [Related]
7. Knowledge, attitude, practice and barriers on vaccination against human papillomavirus infection: a cross-sectional study among primary care physicians in Hong Kong.
Wong MC; Lee A; Ngai KL; Chor JC; Chan PK
PLoS One; 2013; 8(8):e71827. PubMed ID: 23990994
[TBL] [Abstract][Full Text] [Related]
8. Asking about human papillomavirus vaccination and the usefulness of registry validation: a study of young women recruited using Facebook.
Gunasekaran B; Jayasinghe Y; Brotherton JM; Fenner Y; Moore EE; Wark JD; Fletcher A; Tabrizi SN; Garland SM
Vaccine; 2015 Feb; 33(6):826-31. PubMed ID: 25444782
[TBL] [Abstract][Full Text] [Related]
9. Increasing human papillomavirus vaccine acceptability by tailoring messages to young adult women's perceived barriers.
Gerend MA; Shepherd MA; Lustria ML
Sex Transm Dis; 2013 May; 40(5):401-5. PubMed ID: 23588130
[TBL] [Abstract][Full Text] [Related]
10. Knowledge and willingness of parents towards child girl HPV vaccination in Debre Tabor Town, Ethiopia: a community-based cross-sectional study.
Mihretie GN; Liyeh TM; Ayele AD; Belay HG; Yimer TS; Miskr AD
Reprod Health; 2022 Jun; 19(1):136. PubMed ID: 35689288
[TBL] [Abstract][Full Text] [Related]
11. Challenges and lessons from a school-based human papillomavirus (HPV) vaccination program for adolescent girls in a rural Nigerian community.
Egbon M; Ojo T; Aliyu A; Bagudu ZS
BMC Public Health; 2022 Aug; 22(1):1611. PubMed ID: 36002832
[TBL] [Abstract][Full Text] [Related]
12. The Uptake of Human Papillomavirus Vaccination and Its Associated Factors Among Adolescents: A Systematic Review.
Loke AY; Kwan ML; Wong YT; Wong AKY
J Prim Care Community Health; 2017 Oct; 8(4):349-362. PubMed ID: 29161946
[TBL] [Abstract][Full Text] [Related]
13. Acceptability of vaccination against human papillomavirus among women aged 20 to 45 in rural Hunan Province, China: A cross-sectional study.
Qin S; Fu JX; Chen MZ; Meng YT; Xu C; Luo Y
Vaccine; 2020 Jun; 38(30):4732-4739. PubMed ID: 32471777
[TBL] [Abstract][Full Text] [Related]
14. Improvement of Parent's awareness, knowledge, perception, and acceptability of human papillomavirus vaccination after a structured-educational intervention.
Sitaresmi MN; Rozanti NM; Simangunsong LB; Wahab A
BMC Public Health; 2020 Dec; 20(1):1836. PubMed ID: 33256697
[TBL] [Abstract][Full Text] [Related]
15. Perspectives of HPV vaccination among young adults: a qualitative systematic review and evidence synthesis protocol.
Mantina NM; Nakayima Miiro F; Smith J; McClelland DJ; Magrath PA; Madhivanan P
BMJ Open; 2023 Dec; 13(12):e076234. PubMed ID: 38072486
[TBL] [Abstract][Full Text] [Related]
16. Challenges related to human papillomavirus (HPV) vaccine uptake in Minnesota: clinician and stakeholder perspectives.
Yared N; Malone M; Welo E; Mohammed I; Groene E; Flory M; Basta NE; Horvath KJ; Kulasingam S
Cancer Causes Control; 2021 Oct; 32(10):1107-1116. PubMed ID: 34247291
[TBL] [Abstract][Full Text] [Related]
17. Adolescent girls' recommendations for the design of a human papillomavirus vaccination program in Sindh, Pakistan: a qualitative study.
Ali RF; Arif Siddiqi D; Mirza A; Naz N; Abdullah S; Kembhavi G; Tam CC; Offeddu V; Chandir S
Hum Vaccin Immunother; 2022 Nov; 18(5):2045856. PubMed ID: 35240928
[TBL] [Abstract][Full Text] [Related]
18. "I don't Think He Needs the HPV Vaccine Cause Boys Can't Have Cervical Cancer": a Qualitative Study of Latina Mothers' (Mis) Understandings About Human Papillomavirus Transmission, Associated Cancers, and the Vaccine.
Lindsay AC; Delgado D; Valdez MJ; Restrepo E; Guzman YM
J Cancer Educ; 2022 Apr; 37(2):370-378. PubMed ID: 32654037
[TBL] [Abstract][Full Text] [Related]
19. The challenge of HPV vaccination uptake and opportunities for solutions: Lessons learned from Alabama.
Dilley SE; Peral S; Straughn JM; Scarinci IC
Prev Med; 2018 Aug; 113():124-131. PubMed ID: 29800594
[TBL] [Abstract][Full Text] [Related]
20. Barriers and facilitators to human papillomavirus vaccination among Chinese adolescent girls in Hong Kong: a qualitative-quantitative study.
Kwan TT; Chan KK; Yip AM; Tam KF; Cheung AN; Young PM; Lee PW; Ngan HY
Sex Transm Infect; 2008 Jun; 84(3):227-32. PubMed ID: 18256106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
